Related Experiment Video
Updated: Dec 16, 2025

Reconstitution of Msp1 Extraction Activity with Fully Purified Components
Published on: August 10, 2021
Membrane complement regulatory proteins
1Institute for Translational Medicine, University of Pennsylvania School of Medicine, Rm 1254 BRBII/III, 421 Curie Blvd, Philadelphia, PA 19104, USA.
Insights
Cell surface proteins like DAF and CD59 protect tissues from complement damage. Recent studies show these membrane complement regulatory proteins are key in autoimmune diseases and cellular immunity.
Area of Science:
- Immunology
- Cell Biology
- Complement System
Background:
- Cell surface proteins protect host tissues from complement-mediated bystander injury.
- Key proteins include decay-accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46), complement receptor 1 (CR1, CD35), and CD59.
- While rare, abnormal function of these proteins can be linked to disease.
Purpose of the Study:
- To review recent advances in the in vivo biology of membrane complement regulatory proteins.
- To discuss the relevance of these proteins in human disease pathogenesis.
- To explore their therapeutic potential.
Main Methods:
- Review of recent scientific literature and animal model studies.
- Analysis of the role of membrane complement regulatory proteins in immune responses.
- Examination of their involvement in autoimmune and inflammatory diseases.
Main Results:
- Membrane complement regulatory proteins are crucial modulators of tissue injury in autoimmune and inflammatory conditions.
- Emerging evidence indicates a significant role in regulating cellular immunity.
- These proteins offer potential therapeutic targets for various diseases.
Conclusions:
- Membrane complement regulatory proteins are vital in protecting tissues and modulating immune responses.
- Their dysregulation contributes to pathogenesis in autoimmune and inflammatory diseases.
- Further research into their in vivo biology can lead to novel therapeutic strategies.
Abstract:
A number of proteins anchored on the cell surface function to protect host tissues from bystander injury when complement is activated. In humans, they include decay-accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46), complement receptor 1 (CR1, CD35) and CD59. Although disease conditions directly attributable to abnormal function of these proteins are relatively rare, it has become evident from recent studies using animal models that membrane complement regulatory proteins are important modulators of tissue injury in many autoimmune and inflammatory disease settings. Evidence is also emerging to support a role of these proteins in regulating cellular immunity. In this article, we highlight recent advances on the in vivo biology of membrane complement regulatory proteins and discuss their relevance in human disease pathogenesis and therapeutics.
More Related Videos
Related Concept Videos
Global Regulatory Systems
Complement System
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Introduction to Membrane Proteins
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...

